KERAPOC

The primary goal of the KERAPOC project is to develop an innovative tool for the diagnosis and prognosis of keratoconus, a progressive corneal disorder that, if left untreated, can lead to significant vision loss. The project leverages molecular biomarkers to detect the disease in its early stages and predict its progression, offering superior diagnostic accuracy compared to existing methods.

A distinguishing feature of KERAPOC is its focus on the development of a Point-of-Care (PoC) device, enabling ophthalmologists to perform rapid and accurate tests directly in clinical settings. This device integrates advanced molecular analysis technologies with a multiplexed system capable of assessing multiple biomarkers simultaneously. Key milestones of the project include the validation of keratoconus-specific biomarkers and the creation of a minimally invasive method for collecting epithelial samples, facilitating their use in routine clinical practice.

The KERAPOC consortium is committed to both the scientific advancement and commercialisation of this technology. Through its public-private collaboration, the project not only aims to improve keratoconus treatment but also seeks to expand our understanding of corneal pathophysiology. This work paves the way for the development of new therapies and personalised treatment approaches.